U.S. Physical Therapy, Inc. (FRA:UPH)
Germany · Delayed Price · Currency is EUR | Market Cap | 816.87M -24.9% |
| Revenue (ttm) | 683.16M +13.8% |
| Net Income | 6.65M +4.3% |
| EPS | 0.44 -76.8% |
| Shares Out | n/a |
| PE Ratio | 122.83 |
| Forward PE | 20.82 |
| Dividend | 1.57 (2.94%) |
| Ex-Dividend Date | May 22, 2026 |
| Volume | n/a |
| Open | 53.50 |
| Previous Close | 53.00 |
| Day's Range | 53.50 - 53.50 |
| 52-Week Range | 49.60 - 80.50 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 6, 2026 |
About U.S. Physical Therapy
U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance... [Read more]
Financial Performance
In 2025, U.S. Physical Therapy's revenue was $773.34 million, an increase of 16.39% compared to the previous year's $664.43 million. Earnings were $21.57 million, a decrease of -22.20%.
Financial numbers in USD Financial StatementsNews
U.S. Physical Therapy Presented at the BofA Securities 2026 Healthcare Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention ...
U.S. Physical Therapy price target lowered to $90 from $103 at Barrington
Barrington analyst Michael Petusky lowered the firm’s price target on U.S. Physical Therapy (USPH) to $90 from $103 and keeps an Outperform rating on the shares based primarily on “somewhat…
U.S. Physical Therapy price target lowered to $98 from $113 at Citizens
Citizens analyst Constantine Davides lowered the firm’s price target on U.S. Physical Therapy (USPH) to $98 from $113 and keeps an Outperform rating on the shares. Revenue and EBITDA both…
U.S. Physical Therapy Earnings Call Transcript: Q1 2026
Q1 2026 revenue rose 7.9% year-over-year, driven by higher patient volumes and strong commercial rates, despite weather-related disruptions. Guidance for full-year adjusted EBITDA of $102–$106 million was reaffirmed, with hospital partnerships and acquisitions expected to ramp up contributions in the second half.
U.S. Physical Therapy Earnings release: Q1 2026
U.S. Physical Therapy released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
U.S. Physical Therapy Quarterly report: Q1 2026
U.S. Physical Therapy has published its Q1 2026 quarterly earnings report on May 7, 2026.
U.S. Physical Therapy Slides: Q1 2026
U.S. Physical Therapy has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 7, 2026.
U.S. Physical Therapy reports Q1 operating EPS 46c, consensus 52c
Reports Q1 revenue $198.3M, consensus $200.94M. Chris Reading, Chairman and Chief Executive Officer commented, “I want to begin by thanking our partners and clinical teams for their tremendous care an...
U.S. Physical Therapy backs FY26 adjusted EBITDA view $102M-$106M
Management reaffirmed the Company’s full year 2026 adjusted EBITDA guidance of $102.0 million to $106.0 million, which includes the partial year impact of two previously announced hospital affiliation...
U.S. Physical Therapy Reports Record First Quarter Revenue, Reaffirms Full Year Guidance
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call Dates
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy Proxy statement: Proxy filing
U.S. Physical Therapy filed a proxy statement on April 16, 2026, providing details for shareholder voting and corporate governance matters.
U.S. Physical Therapy announces $450M credit facility
U.S. Physical Therapy (USPH) announced the closing of a $450M, five-year credit facility that includes a $175M term loan and a $275M revolver with a maturity date of April 14,…
U.S. Physical Therapy Announces $450 Million Credit Facility
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy Presented at the Barclays 28th Annual Global Healthcare Conference
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy assumed with a Buy at Jefferies
Jefferies assumed coverage of U.S. Physical Therapy (USPH) with a Buy rating and a price target of $102, down from $110. As the company pursues strategic hospital alliances and faces…
U.S. Physical Therapy Earnings Call Transcript: Q4 2025
Adjusted EBITDA and net revenue grew over 16% year-over-year, with record patient visit volumes and strong margin improvement despite Medicare headwinds. Two exclusive hospital alliances and multiple acquisitions are set to drive further growth and margin expansion in 2026.
U.S. Physical Therapy Annual report: Q4 2025
U.S. Physical Therapy has published its Q4 2025 annual report on February 26, 2026.
U.S. Physical Therapy Earnings release: Q4 2025
U.S. Physical Therapy released its Q4 2025 earnings on February 26, 2026, summarizing the period's financial results.
U.S. Physical Therapy Slides: Q4 2025
U.S. Physical Therapy has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on February 26, 2026.
U.S. Physical Therapy reports Q4 non-GAAP EPS 67c, consensus 67c
Reports Q4 revenue $202.73M, consensus $200.1M. CEO Chris Reading said, “Our team delivered a strong finish to a solid year where we made progress around a number of key initiatives…
U.S. Physical Therapy sees 2026 adjusted EBITDA $102.0M-$106.0M
18:33 EST U.S. Physical Therapy (USPH) sees 2026 adjusted EBITDA $102.0M-$106.0M
U.S. Physical Therapy Reports Fourth Quarter and Full Year 2025 Results
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy, Inc. Schedules Fourth Quarter and Year Ended December 31, 2025 Earnings Release and Conference Call Dates
HOUSTON--(BUSINESS WIRE)--U.S. Physical Therapy, Inc. (“USPH” or the “Company”) (NYSE, NYSE Texas: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury p...
U.S. Physical Therapy acquires industrial injury prevention business
U.S. Physical Therapy (USPH) announced the acquisition of an industrial injury prevention business for approximately $15.1 million. The business currently generates approximately $7.0 million in annua...